Ambulatory Aortic Stiffness Is Associated With Narrow Retinal Arteriolar Caliber in Hypertensives: The SAFAR Study

Evaggelia K Aissopou1, Antoniοs A Argyris2, Efthimia G Nasothimiou2

  • 1Hypertension Unit and Cardiovascular Research Laboratory, 1st Department of Propaedeutic Internal Medicine, Laiko Hospital, Athens, Greece; eaiswpou@yahoo.gr.

Insights

Ambulatory aortic pulse wave velocity (aPWV) measurements provide additional cardiovascular risk insights beyond static measures, associating with narrower retinal arterioles. This 24-hour monitoring better reflects usual arterial stiffness and its impact on eye vessels.

Area of Science:

  • Cardiovascular research
  • Ophthalmology
  • Vascular biology

Background:

  • Static arterial stiffness measurements incompletely represent usual cardiovascular risk due to circadian variation.
  • Arterial stiffness is linked to narrower retinal arterioles, an indicator of vascular health.
  • Current methods may not capture the full picture of arterial stiffness's impact.

Purpose of the Study:

  • To test if ambulatory 24-hour aortic pulse wave velocity (aPWV) associates with retinal vessel calibers.
  • To determine if this association is independent of confounders and static arterial stiffness.
  • To investigate awake and asleep aPWV in hypertensive individuals without diabetes or cardiovascular disease.

Main Methods:

  • Retinal images were analyzed to measure central retinal arteriolar and venular equivalents (CRAE and CRVE).
  • Ambulatory (24-hour, awake, asleep) and static office aPWV were measured using Mobil-O-Graph.
  • Static office carotid-femoral PWV (cfPWV) was measured using SphygmoCor.

Main Results:

  • Ambulatory aPWV correlated with narrower retinal arterioles, but not venules, after adjustments.
  • Asleep aPWV showed a stronger association with CRAE than awake aPWV.
  • Both ambulatory aPWV and cfPWV independently associated with narrower retinal arterioles, with aPWV improving cfPWV models.

Conclusions:

  • Ambulatory aPWV offers additional cardiovascular risk information beyond cfPWV.
  • Operator-independent ambulatory aPWV measurement enhances understanding of arterial stiffness and retinal vessel caliber associations.
  • This method provides a more comprehensive assessment of arterial stiffness's impact on ocular vasculature.
Abstract

Related Concept Videos

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...
681
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
1.5K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
723
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
754